SINDOLOR
We develop cannabis-containing pharmaceuticals for pain and other therapeutic markets. We have already successfully conducted an exploratory Phase I/proof of concept trial for our first medicine, which is a complete opioid replacement for both chronic and acute pain. Other pre-clinical drugs in our pipeline include treatments for nausea and vomiting, neuropathy, and veterinary pain management.
SINDOLOR
Industry:
Biotechnology Pharmaceutical
Founded:
2004-05-04
Total Employee:
1+
Status:
Active